Evaluation of BromAc® as a potent mucolytic for thick purulent sputum in Obstructive Lung Disease. - Amsterdam 2025

Unblocking the airways: innovations in mucus-targeted therapy and novel data on phosphodiesterase inhibitors

Chair(s): Efthymia Papadopoulou, Alejandro A Diaz

Session type: Poster session

Evaluation of BromAc® as a potent mucolytic for thick purulent sputum in Obstructive Lung Disease.

Mathew Eapen

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Effectiveness of Erdosteine plus SITT (single inhaler triple therapy) in preventing exacerbation in comparsion to SITT in Non-smoker COPD: A muticenter study

Ashok Kuwal

Poster

Abstract

Roflumilast in COPD: qualitative analysis of Greek Pulmonologists prescribing practice

Efthymia Papadopoulou

Poster

Abstract

Impact of mucociliary clearance on the dissolution and absorption of micro drugs in airway surface liquid

Mohammadhadi Sedaghat

Poster

Abstract

Targeting PDE4 to promote lung repair in COPD

Valentina Violi

Poster

Abstract

Effectiveness and tolerability of acebrophylline in patients with chronic obstructive pulmonary disease: a real-world retrospective study from electronic medical records

Chintan Khandhedia

Poster

Abstract

Characterization of bronchoconstrictor response during induced sputum induction in asthmatic patients

Cristina Buccheri

Poster

Abstract

Efficacy of low-dose theophylline for treatment-naïve biomass-associated COPD: a pilot randomized trial.

Patricia Alupo

Poster

Abstract

Evaluation of BromAc® as a potent mucolytic for thick purulent sputum in Obstructive Lung Disease.

Mathew Eapen

Poster

Abstract

Safety and efficacy of nebulized BromAc® in asthma: preclinical models

Sarah Valle

Poster

Abstract

Mepolizumab effectiveness on mucus plug in severe eosinophilic asthma

Raffaele Campisi

Poster

Abstract

The effect of ensifentrine on lung function and exacerbations in patients with COPD according to baseline dyspnea

Frits M.e. Franssen

Poster

Abstract

Asthma Control and Quality of Life in Greek Asthma Patients With Allergic Rhinitis Treated With Budesonide/Formoterol FDC: A Subgroup Analysis From the NOTOS Study

Maria Bertoli

Poster

Abstract

Efficacy of ivy leaf dry extract EA575 in an acute inflammation animal model

Matthias Hufnagel

Poster

Abstract

Ensifentrine induces anti-inflammatory effects in isolated airways from COPD donors

Luigino Calzetta

Poster

Abstract

Focused Pulse High-Frequency Chest Wall Oscillation (FP-HFCWO) for Mucus Clearance in COPD and Asthma: A Single-Center Experience

Pier-valerio Mari

Abstract

Acceptability of an oscillating positive expiratory pressure (OPEP) device by respiratory disease patients

Jason Suggett

Poster

Abstract

Ivy leaves dry extract EA575 shows mucoactive, antitussive, and anti-inflammatory activity in vivo

Natalia Machajewski

Poster

Abstract

Evaluation of effectiveness of nebulized hypertonic sodium chloride solution and its combination with hyaluronic acid in patients with stable COPD

Dmytro Dobrianskyi

Poster

Abstract

The effect of ensifentrine on COPD symptoms and quality of life according to baseline dyspnea level

Jadwiga A Wedzicha

Poster

Abstract

Proteomic analysis of sputum samples for the isolation and characterization of mucins in patients with bronchial asthma: a pilot study

Despoina Ioannidou

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}